This site is intended for healthcare professionals

NIH- sponsored trial finds Eylea reduced vision threatening complications by 68% after two years in diabetic retinopathy patients .- Regeneron + Bayer

Read time: 3 mins
Last updated:8th Apr 2021
Published:8th Apr 2021
Condition: Diabetic Retinopathy
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest